{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:27:13Z","timestamp":1780471633252,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T00:00:00Z","timestamp":1221523200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s10067-008-0999-5","type":"journal-article","created":{"date-parts":[[2008,9,15]],"date-time":"2008-09-15T09:14:09Z","timestamp":1221470049000},"page":"153-158","source":"Crossref","is-referenced-by-count":50,"title":["A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis"],"prefix":"10.1007","volume":"28","author":[{"given":"Lisiane Maria","family":"Enriconi dos Anjos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivanio Alves","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"d \u2018Orsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Piette","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufus Watson","family":"Burlingame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edelton Flavio","family":"Morato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,16]]},"reference":[{"key":"999_CR1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.1780390502","volume":"39","author":"American College of Rheumatology Ad Hoc Committee on Clinical Guidelines","year":"1996","unstructured":"American College of Rheumatology Ad Hoc Committee on Clinical Guidelines (1996) Guideline arthritis. Arthritis Rheum 39:713\u2013722","journal-title":"Arthritis Rheum"},{"key":"999_CR2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/art.10148","volume":"46","author":"American College of Rheumatology Ad Hoc Committee on Clinical Guidelines","year":"2002","unstructured":"American College of Rheumatology Ad Hoc Committee on Clinical Guidelines (2002) Guideline arthritis: 2002 Update. Arthritis Rheum 46:328\u2013346","journal-title":"Arthritis Rheum"},{"key":"999_CR3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/ar395","volume":"4","author":"MAM Boekel van","year":"2002","unstructured":"van Boekel MAM, Vossenaar ER, van den Hoogent FHJ, Venrooij WJ (2002) Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 4:87\u201393","journal-title":"Arthritis Res"},{"key":"999_CR4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar551","volume":"4","author":"G Steiner","year":"2002","unstructured":"Steiner G, Smolen J (2002) Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 4:S1\u2013S5","journal-title":"Arthritis Res"},{"key":"999_CR5","first-page":"1","volume-title":"Manual of Biological Markers of Disease","author":"RA Mageed","year":"1996","unstructured":"Mageed RA (1996) The RF antigen. In: van Venrooij WJ, Maini RN (eds) Manual of Biological Markers of Disease. Kluwer Academic, Dordrecht, B1.1, pp 1\u201327"},{"key":"999_CR6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.23.4.302","volume":"23","author":"RLF Nienhuis","year":"1964","unstructured":"Nienhuis RLF, Mandena EA (1964) A new serum factor in patients with rheumatoid arthritis. The antiperinuclear factor. Ann Rheum Dis 23:302\u2013305","journal-title":"Ann Rheum Dis"},{"key":"999_CR7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/ard.40.3.263","volume":"40","author":"GD Johnson","year":"1981","unstructured":"Johnson GD, Carvalho A, Holborow EJ, Goddard DH, Russell G (1981) Antiperinuclear factor and keratin antibodies in rheumatoid arthritis. Ann Rheum Dis 40:263\u2013266","journal-title":"Ann Rheum Dis"},{"key":"999_CR8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-3-642-76189-8_20","volume-title":"Rheumatoid arthritis","author":"RM Hoet","year":"1992","unstructured":"Hoet RM, Van Venrooij WJ (1992) The antiperinuclear factor and antikeratin antibodies in rheumatoid arthritis. In: Smolen J, Kalden J, Maini RN (eds) Rheumatoid arthritis. Springer, Berlin, pp 299\u2013318"},{"key":"999_CR9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.2.6182.97","volume":"2","author":"BJJ Young","year":"1979","unstructured":"Young BJJ, Mallya RK, Leslie RDG, Clark CJM, Hamblin TJ (1979) Anti-keratin antibodies in rheumatoid arthritis. Br Med J 2:97\u201399","journal-title":"Br Med J"},{"key":"999_CR10","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI117969","volume":"95","author":"M Sebbag","year":"1995","unstructured":"Sebbag M, Simon M, Vincent C, Masson-Bessiere C, Girbal E, Duri JJ (1995) The antiperinuclear factor and the so-called antikeratin are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 95:2672\u20132679","journal-title":"J Clin Invest"},{"key":"999_CR11","first-page":"838","volume":"25","author":"C Vincent","year":"1998","unstructured":"Vincent C, Simon M, Sebbag M, Girlbal-Neuhauser E, Durieux JJ, Cantagrel A, Fournie B, Mazieres B, Serre G (1998) Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol 25:838\u2013846","journal-title":"J Rheumatol"},{"key":"999_CR12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1297-319X(01)00259-7","volume":"68","author":"G Serre","year":"2001","unstructured":"Serre G (2001) Autoantibodies to filaggrin\/deiminated fibrin (AFA) are useful for the diagnosis and prognosis of rheumatoid arthritis, and are probably involved in the pathophysiology of the disease. Jt Bone Spine 68:103\u2013105","journal-title":"Jt Bone Spine"},{"key":"999_CR13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","volume":"101","author":"GA Schellekens","year":"1998","unstructured":"Schellekens GA, de Jong BAW, van den Hoogen FHJ, van de Putte LBA (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101:273\u2013281","journal-title":"J Clin Invest"},{"key":"999_CR14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","volume":"162","author":"E Girbal-Neuhauser","year":"1999","unstructured":"Girbal-Neuhauser E, Durieux J-J, Arnaud M, Dalbon P, Sebbag M, Vincent C, Simon M, Senshu T, Masson-Bessiere C, Jolivet- Reynaud C, Jolivet M, Serre G (1999) The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 162:585\u2013594","journal-title":"J Immunol"},{"key":"999_CR15","first-page":"86","volume":"42","author":"E Lapointe","year":"1999","unstructured":"Lapointe E, Dery U, Vaillanciurt F, Menard HA (1999) Rheumatoid sera potentially recognize all citrullinated proteins. Arthritis Rheum 42:86","journal-title":"Arthritis Rheum"},{"key":"999_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2249.2004.02341.x","volume":"135","author":"O Vittecoq","year":"2004","unstructured":"Vittecoq O, Incaurgarat B, Jouen-Beades F, Legoedec J, Letourneur O, Rolland D, Gervasi G, Menard JF, Gayet A, Fardellone P, Daragon A, Jolivet M, Ie Loet X, Tron F (2004) Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis. Clin Exp Immunol 135:173\u2013180","journal-title":"Clin Exp Immunol"},{"key":"999_CR17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BAW, Van Den Hoogen FHJ, Hazes JMW, Breedveld FC, Van Venrooij WJ (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155\u2013163","journal-title":"Arthritis Rheum"},{"key":"999_CR18","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/ard.2004.035089","volume":"64","author":"FA Gaalen Van","year":"2005","unstructured":"Van Gaalen FA, Visser H, Huizinga TW (2005) A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis. Ann Rheum Dis 64:1510\u20131512","journal-title":"Ann Rheum Dis"},{"key":"999_CR19","first-page":"2535","volume":"30","author":"A Saraux","year":"2004","unstructured":"Saraux A, Berthelot JM, Devauchelle V, Bendaoud B, Chal\u00e8s G, Le Henaff C, Thorel JB, Hoang S, Jousse S, Baron D, Le Goff P, Youinou P (2004) Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis. J Rheumatol 30:2535\u20132539","journal-title":"J Rheumatol"},{"key":"999_CR20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1196\/annals.1313.033","volume":"1050","author":"U Sauerland","year":"2005","unstructured":"Sauerland U, Becker H, Seide M, Schotte H, Willeke P, Schorat A, Schluter B, Domschke W, Gaubitz M (2005) Clinical utility of the anti-CCP assay: experiences with 700 patients. Ann NY Acad Sci 1050:314\u2013318","journal-title":"Ann NY Acad Sci"},{"key":"999_CR21","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/ard.2003.019877","volume":"63","author":"I Vallbracht","year":"2004","unstructured":"Vallbracht I, Rieber J, Oppermann M, Forger F, Siebert U, Helmke K (2004) Diagnostic and clinical value of anti-cyclic citrulinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 63:1079\u20131084","journal-title":"Ann Rheum Dis"},{"key":"999_CR22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.patbio.2004.04.019","volume":"53","author":"P Dubrous","year":"2005","unstructured":"Dubrous P, Gardet V, Hugard L (2005) Value of anti-cyclic citrullinated peptides antibodies in comparison with rheumatoid factor for rheumatoid arthritis diagnosis. Pathol Biol 53:63\u201367","journal-title":"Pathol Biol"},{"key":"999_CR23","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s10067-007-0601-6","volume":"26","author":"IG Silveira","year":"2007","unstructured":"Silveira IG, Burlingame RW, von M\u00fchlen CA, Bender AL, Staub HL (2007) Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF. Clin Rheumatol 26:1883\u20131889","journal-title":"Clin Rheumatol"},{"key":"999_CR24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.autrev.2005.02.001","volume":"4","author":"I Vallbracht","year":"2005","unstructured":"Vallbracht I, Helmke K (2005) Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Autoimmun Rev 4:389\u2013394","journal-title":"Autoimmun Rev"},{"key":"999_CR25","first-page":"1097","volume":"117","author":"K Solanki","year":"2004","unstructured":"Solanki K, Spellerberg M, Chapman P, Moller P, O\u2019Donnell J (2004) Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis. N Z Med J 117:1097","journal-title":"N Z Med J"},{"key":"999_CR26","first-page":"966","volume":"52","author":"C Araki","year":"2004","unstructured":"Araki C, Hayashi N, Moriyama M, Morinobu S, Mukai M, Koshiba M, Kawano S, Kumagai S (2004) Usefulness of anti-cyclic citrullinated peptide antibodies (anti-CCP) for the diagnosis of rheumatoid arthritis. Rinsho Byori 52:966\u2013972","journal-title":"Rinsho Byori"},{"key":"999_CR27","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","volume":"65","author":"J Avouac","year":"2006","unstructured":"Avouac J, Gossec L, Dougados M (2006) Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 65:845\u2013851","journal-title":"Ann Rheum Dis"},{"key":"999_CR28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","volume":"146","author":"K Nishimura","year":"2007","unstructured":"Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Kamae I, Kumagai S (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146:797\u2013808","journal-title":"Ann Intern Med"},{"key":"999_CR29","first-page":"127","volume":"36","author":"F Girelli","year":"2004","unstructured":"Girelli F, Foscbi FG, Bedescbi E, Calderoni V, Stefanini GF, Martinelli MG (2004) Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis? Allerg Immunol 36:127\u2013130","journal-title":"Allerg Immunol"},{"key":"999_CR30","doi-asserted-by":"crossref","first-page":"R303","DOI":"10.1186\/ar1187","volume":"6","author":"E Berglin","year":"2004","unstructured":"Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, van Venrooij WJ, Klareskog L, Dahlqvist SR (2004) A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther 6:R303\u2013R308","journal-title":"Arthritis Res Ther"},{"key":"999_CR31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MJ Nielen","year":"2004","unstructured":"Nielen MJ, van Shaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinima IE, Dekoning MHMT, Habibuw MR, Vandenbroucke JP, Dijkmans BAC (2004) Specific autoantibodies precede the symptoms of Rheumatoid Arthritis. Arthritis Rheum 50:380\u2013386","journal-title":"Arthritis Rheum"},{"key":"999_CR32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/art.20044","volume":"50","author":"FA Gaalen Van","year":"2004","unstructured":"Van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CC, Toes REM, Huizinga TWJ (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study. Arthritis Rheum 50:709\u2013715","journal-title":"Arthritis Rheum"},{"key":"999_CR33","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","volume":"64","author":"J Rormelid","year":"2005","unstructured":"Rormelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, van Vollenhoven RF (2005) Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CCP) during 5\u00a0year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 64:1744\u20131749","journal-title":"Ann Rheum Dis"},{"key":"999_CR34","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2003.017574","volume":"63","author":"L Rycke De","year":"2004","unstructured":"De Rycke L, Peene I, De Keyser F (2004) Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis 63:1587\u20131593","journal-title":"Ann Rheum Dis"},{"key":"999_CR35","first-page":"689","volume":"17","author":"CD Jaarsveld van","year":"1999","unstructured":"van Jaarsveld CD, ter Borg EJ, Jacobs JW, Schellekens GA, Gmelig-Meyling FH, van Booma-Frankfort C, de Jong BA, van Venrooij WJ, Bijlsma JW (1999) The prognostic value of the antiperinuclear factor, anticitrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol 17:689\u2013697","journal-title":"Clin Exp Rheumatol"},{"key":"999_CR36","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1002\/art.22279","volume":"54","author":"KN Verpoort","year":"2006","unstructured":"Verpoort KN, Jol-van der Zijde CM, Papendrecht-van der Voort EA, Ioan-Facsinay A, Drijfhout JW, van Tol MJ, Breedveld FC, Huizinga TW, Toes RE (2006) Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum 54:3799\u20133808","journal-title":"Arthritis Rheum"},{"key":"999_CR37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10067-007-0656-4","volume":"27","author":"M Santiago","year":"2008","unstructured":"Santiago M, Baron M, Miyachi K, Fritzler MJ, Abu-Hakima M, Leclercq S, Bell M, Hudson M, Mathieu JP, Taillefer S, Jones N, Docherty P, Khraishi M, Markland J, Pope J, Robinson D, Smith D, Sutton E (2008) A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis. Clin Rheumatol 27:77\u201383","journal-title":"Clin Rheumatol"},{"key":"999_CR38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02686081","volume":"32","author":"R Wu","year":"2007","unstructured":"Wu R, Shovman O, Zhang Y, Gilburd B, Zandman-Goddard G, Shoenfeld Y (2007) Increased prevalence of anti-third generation cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and CREST syndrome. Clin Rev Allergy Immunol 32:47\u201356","journal-title":"Clin Rev Allergy Immunol"},{"key":"999_CR39","first-page":"1725","volume":"40","author":"American College of Rheumatology","year":"1997","unstructured":"American College of Rheumatology (1997) Revised Criteria for the Classification of Systemic Lupus Erythematosus. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"999_CR40","unstructured":"Classification Criteria of Rheumatoid Arthrites, 1987. www.rheumatology.org\/publications\/classification\/ra\/1987 (accessed Dec 2007)"},{"key":"999_CR41","first-page":"47","volume":"25","author":"JB Martinez","year":"2007","unstructured":"Martinez JB, Valero JS, Bautista AJ, Restrepo JF, Matteson EL, Rondon F, Iglesias-Gamarra A (2007) Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature. Clin Exp Rheumatol 25:47\u201353","journal-title":"Clin Exp Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-008-0999-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-008-0999-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-008-0999-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T23:25:49Z","timestamp":1684538749000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-008-0999-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,16]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["999"],"URL":"https:\/\/doi.org\/10.1007\/s10067-008-0999-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,16]]}}}